BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4268482)

  • 21. Distribution of carbohydrate among the polypeptide chains and plasmin digest products of human fibrinogen.
    Mills DA; Triantaphyllopoulos DC
    Arch Biochem Biophys; 1969 Dec; 135(1):28-35. PubMed ID: 4243528
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of plasmin on the subunit structure of human fibrin.
    Pizzo SV; Schwartz ML; Hill RL; McKee PA
    J Biol Chem; 1973 Jul; 248(13):4574-83. PubMed ID: 4268861
    [No Abstract]   [Full Text] [Related]  

  • 23. Production, purification and partial characterization of staphylokinase.
    Arvidson S; Eriksson R; Holme T; Möllby R; Wadström T; Vesterberg O
    Contrib Microbiol Immunol; 1973; 1():406-12. PubMed ID: 4281732
    [No Abstract]   [Full Text] [Related]  

  • 24. Fate of fibrinopeptides in the reaction between human plasmin and fibrinogen.
    Lahiri B; Shainoff JR
    Biochim Biophys Acta; 1973 Mar; 303(1):161-70. PubMed ID: 4267201
    [No Abstract]   [Full Text] [Related]  

  • 25. A sensitive fluorometric assay for plasminogen, plasmin, and streptokinase.
    Bell PH; Dziobkowski CT; Englert ME
    Anal Biochem; 1974 Sep; 61(1):200-8. PubMed ID: 4277983
    [No Abstract]   [Full Text] [Related]  

  • 26. Interaction of streptokinase and human plasminogen. IV. Further gel electrophoretic studies on the combination of streptokinase with human plasminogen or human plasmin.
    De Renzo EC; Boggiano E; Barg WF; Buck FF
    J Biol Chem; 1967 May; 242(10):2428-34. PubMed ID: 4226006
    [No Abstract]   [Full Text] [Related]  

  • 27. Amino acid sequence of the light chain derived from a rabbit anti-p-azobenzoate antibody of restricted heterogeneity.
    Appella E; Roholt OA; Chersi A; Radzimski G; Pressman D
    Biochem Biophys Res Commun; 1973 Aug; 53(4):1122-9. PubMed ID: 4748811
    [No Abstract]   [Full Text] [Related]  

  • 28. Identification of macromolecules by quantitative polyacrylamide gel electrophoresis and isoelectric focusing: a comparison of three approaches.
    Muñiz N; Rodbard D; Chrambach A
    Anal Biochem; 1977 Dec; 83(2):724-38. PubMed ID: 146442
    [No Abstract]   [Full Text] [Related]  

  • 29. Molecular forms of plasmin and protease inhibitors in human fibrinolytic post-mortem plasma.
    Müllertz S
    Scand J Clin Lab Invest; 1972 Dec; 30(4):369-79. PubMed ID: 4118172
    [No Abstract]   [Full Text] [Related]  

  • 30. A partially degraded form of human plasminogen in circulating blood.
    Yamamoto J; Okamoto U; Kojima S; Morita S; Fujii K
    Clin Lab Haematol; 1982; 4(2):117-30. PubMed ID: 6214361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human plasminogen: in vitro and in vivo evidence for the biological integrity of NH2-terminal glutamic acid plasminogen.
    Collen D; Ong EB; Johnson AJ
    Thromb Res; 1975 Oct; 7(4):515-29. PubMed ID: 1081757
    [No Abstract]   [Full Text] [Related]  

  • 32. NH2-terminal sequences of mammalian plasminogens and plasmin S-carboxymethyl heavy (A) and light (B) chain derivatives. A re-evaluation of the mechanism of activation of plasminogen.
    Robbins KC; Bernabe P; Arzadon L; Summaria L
    J Biol Chem; 1973 Oct; 248(20):7242-6. PubMed ID: 4270330
    [No Abstract]   [Full Text] [Related]  

  • 33. Lower molecular weight species of alpha 2-macroglobulin-plasmin complexes in human plasma activated by urokinase.
    Yamamoto J; Okamoto U
    Nihon Ketsueki Gakkai Zasshi; 1985 Jul; 48(4):1090-9. PubMed ID: 2414954
    [No Abstract]   [Full Text] [Related]  

  • 34. Plasminogen-plasmin system. V. A stoichiometric equilibrium complex of plasminogen and a synthetic inhibitor.
    Abiko Y; Iwamoto M; Tomikawa M
    Biochim Biophys Acta; 1969; 185(2):424-31. PubMed ID: 4241289
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of epsilon-amino caproic acid on the gross conformation of plasminogen and plasmin.
    Violand BN; Sodetz JM; Castellino FJ
    Arch Biochem Biophys; 1975 Sep; 170(1):300-5. PubMed ID: 126043
    [No Abstract]   [Full Text] [Related]  

  • 36. Covalent molecular weight approximately 92 000 hybrid plasminogen activator derived from human plasmin amino-terminal and urokinase carboxyl-terminal domains.
    Robbins KC; Tanaka Y
    Biochemistry; 1986 Jun; 25(12):3603-11. PubMed ID: 2941075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein composition of plasmin preparation "homolysin".
    Nguyen NY; Chrambach A
    Prep Biochem; 1981; 11(2):159-72. PubMed ID: 6454129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of molecular forms of plasminogen and plasmin-inhibitor complexes in urokinase-activated human plasma.
    Müllertz S; Thorsen S; Sottrup-Jensen L
    Biochem J; 1984 Oct; 223(1):169-77. PubMed ID: 6208893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distribution of plasminogen and plasmin in fractions of bovine milk.
    Politis I; Barbano DM; Gorewit RC
    J Dairy Sci; 1992 Jun; 75(6):1402-10. PubMed ID: 1386854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on the purification and characterization of human urinary plasminogen and plasmin.
    Chen HF; Nakabayashi M; Satoh K; Sakamoto S
    Thromb Haemost; 1980 Feb; 42(5):1536-47. PubMed ID: 6445089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.